Peter Welford analyst JEFFERIES

Currently, out of the existing stock ratings of Peter Welford - 23 which are a Hold (44.23%), 25 which are a Buy (48.08%), 4 which are a Sell (7.69%)

Peter Welford

Work Performance Price Targets & Ratings Chart

Analyst Peter Welford works at JEFFERIES and is covering the Healthcare sector with 89 price targets and ratings displayed on 10 stocks.

Peter Welford's average stock forecast success ratio is 35.37% with an average time for price targets to be met of 461.89 days.

Most recent stock forecast was given on AZN, AstraZeneca PLC at 25-Sep-2023.

Wall Street Analyst Peter Welford

Analyst best performing recommendations are on CGEN (COMPUGEN LTD).
The best stock recommendation documented was for AZN (ASTRAZENECA PLC) at 7/20/2020. The price target of $50 was fulfilled within 52 days with a profit of $4.55 (8.34%) receiving and performance score of 1.6.

Average potential price target upside

AZN AstraZeneca PLC GSK GlaxoSmithKline plc PLX Protalix BioTherapeutics CGEN Compugen Ltd GLPG Galapagos NV GMAB Genmab A/S NVO NVS Novartis AG SNY RHHBY

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score



$12.06 (17.75%)

3 days ago

3/5 (60%)

$17.92 (32.06%)




2 months 14 days ago

0/2 (0%)

$56.72 (106.69%)


2 months 16 days ago

0/2 (0%)

$56.95 (106.34%)



2 months 23 days ago

0/3 (0%)

$77.98 (168.75%)



$12.06 (17.75%)


4 months 2 days ago

1/3 (33.33%)

$9.27 (13.19%)


Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Peter Welford is most bullish on?

Potential upside of $12.06 has been obtained for AZN (ASTRAZENECA PLC)

What Year was the first public recommendation made by Peter Welford?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart